The FDA has approved a new drug called Trelstar (triptorelin) for the treatment of advanced prostate cancer. Trelstar works by lowering testosterone levels in the body, which can help slow the growth of prostate cancer cells. It is a type of hormone therapy known as a GnRH agonist.
This drug is given as a shot into a muscle, usually in the buttock. It comes in three different doses: a shot every 4 weeks, every 12 weeks, or every 24 weeks. Your doctor will choose the schedule that is right for you. The drug is a powder that must be mixed with sterile water and injected within 2 minutes.
This approval gives patients and doctors more flexibility in choosing a treatment plan. It is an additional option for managing advanced prostate cancer. However, it is important to remember that Trelstar is not a cure. It is a treatment that helps control the disease.
If you or a loved one has advanced prostate cancer, talk to your doctor about whether Trelstar might be a good option. Your doctor can help you understand the benefits and risks based on your specific health situation.
